Mather L E, Selby D G, Runciman W B
Department of Anaesthesia and Intensive Care, Flinders University of South Australia, Adelaide.
Br J Anaesth. 1990 Sep;65(3):365-72. doi: 10.1093/bja/65.3.365.
We have examined the extraction ratios, net fluxes and clearances of pethidine by the liver, kidneys and hindquarters in sheep before, during and after continuous anaesthesia (70 min) with propofol or thiopentone. Before anaesthesia, the overall mean respective regional pethidine extraction ratios were 0.98 (SD 0.01), 0.20 (0.06) and 0.44 (0.13), the corresponding net fluxes were 47 (7), 5 (2) and 20 (10)% dose min-1 and the clearances 1.44 (0.22), 0.17 (0.07) and 0.80 (0.39) litre min-1. During propofol anaesthesia, arterial blood concentrations of pethidine approximately doubled (P less than 0.05), mean pethidine hepatic extraction ratio was unchanged, flux was increased to 145 (20)% and clearance decreased to 79 (10)% (P less than 0.05) of baseline values; mean pethidine renal extraction ratio, flux and clearance were 73 (34), 112 (43) and 69 (31)% of baseline values; mean hindquarter pethidine extraction ratio decreased to 65 (25)% (P less than 0.05) of baseline values. During thiopentone anaesthesia, arterial blood concentrations of pethidine approximately doubled (P less than 0.01), mean pethidine hepatic extraction ratio was 97 (2)% of baseline values and flux and clearance were unchanged, mean pethidine renal extraction ratios, flux and clearance decreased to 37 (21), 54 (18) and 27 (19)% (all P less than 0.05) of baseline values and mean pethidine hindquarter extraction ratio was 81 (20)% of baseline values. In spite of only modest changes in hepatic and renal blood flow during anaesthesia, blood concentrations of pethidine doubled and pethidine kinetics were disturbed for several hours after anaesthesia. Overall, however, the changes were of smaller magnitude and shorter duration than those that have been described for anaesthesia with the volatile anaesthetic agents.
我们研究了绵羊在丙泊酚或硫喷妥钠持续麻醉(70分钟)之前、期间和之后,肝脏、肾脏及后肢对哌替啶的提取率、净通量和清除率。麻醉前,各区域哌替啶的总体平均提取率分别为0.98(标准差0.01)、0.20(0.06)和0.44(0.13),相应的净通量分别为47(7)、5(2)和20(10)%剂量·分钟⁻¹,清除率分别为1.44(0.22)、0.17(0.07)和0.80(0.39)升·分钟⁻¹。丙泊酚麻醉期间,哌替啶的动脉血浓度约增加一倍(P<0.05),哌替啶肝脏提取率未变,通量增加至145(20)%,清除率降至基线值的79(10)%(P<0.05);哌替啶肾脏提取率、通量和清除率分别为基线值的73(34)、112(43)和69(31)%;后肢哌替啶提取率降至基线值的65(25)%(P<0.05)。硫喷妥钠麻醉期间,哌替啶的动脉血浓度约增加一倍(P<0.01),哌替啶肝脏提取率为基线值的97(2)%,通量和清除率未变,哌替啶肾脏提取率、通量和清除率分别降至基线值的37(21)、54(18)和27(19)%(均P<0.05),后肢哌替啶提取率为基线值的81(20)%。尽管麻醉期间肝脏和肾脏血流仅有适度变化,但哌替啶血药浓度增加一倍,且麻醉后数小时哌替啶动力学受到干扰。然而总体而言,这些变化的幅度和持续时间比使用挥发性麻醉剂麻醉时所描述的要小和短。